Cid Xutglà, M. Cinta
Maria Cinta Cid i Xutglà ikertzailea
Cid, Maria C.
VIAF ID: 264870002 (Personal)
Permalink: http://viaf.org/viaf/264870002
Preferred Forms
- 100 1 _ ‡a Cid Xutglà, M. Cinta
-
- 100 1 _ ‡a Cid Xutglà, M. Cinta
- 100 1 _ ‡a Cid, Maria C.
- 100 0 _ ‡a Maria Cinta Cid i Xutglà ‡c ikertzailea
4xx's: Alternate Name Forms (7)
Works
Title | Sources |
---|---|
2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. | |
Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis. | |
Avances en vasculitis sistémicas, 2012: | |
A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCA | |
Clinical and genetic characterization of the autoinflammatory diseases diagnosed in an adult reference center | |
The cryoglobulinaemias | |
Description and Validation of Histological Patterns and Proposal of a Dynamic Model of Inflammatory Infiltration in Giant-cell Arteritis | |
Diferenciació funcional Th17 en l'expressió fenotípica i evolució clínica de l'arteritis de cèl·lules gegants. Rol de l'axis IL23/IL-17 en la inflamació vascular | |
Dual function of focal adhesion kinase in regulating integrin-induced MMP-2 and MMP-9 release by human T lymphoid cells | |
Endothelial and myointimal cell functions related to vascular inflammation and remodeling in Giant-Cell Arteritis : contribution of interleukin-23p19, interleukin-35 and endothelin-1 | |
Estudio inmunogenético e inmunohistoquímico de la arteritis de Horton | |
Expressió de les molècules d'adhesió cel·lular en les vasculitis de vas gran i vas mitjà | |
Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors. | |
Imaging in systemic vasculitis | |
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. | |
Implicaciones clínicas y pronósticas de la expresión de citocinas proinflamatorias en la arteritis de células gigantes | |
Integrinas y degradación de la matriz extracelular durante el proceso de transmigración linfocitaria | |
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility | |
Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients | |
Les malalties autoimmunes a l'Hospital Clínic de Barcelona (1986-2011) = Enfermedades autoinmunes, memorias = autoimmune diseases, report | |
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis | |
Patient-reported outcomes in polymyalgia rheumatica. | |
Persistence of inflammatory activity in giant cell arteritis role of the angiotensin II system | |
Regulació de la producció de gelatinases (MMP2 i MMP9) pels limfòcits : implicació en malalties inflamatòries i síndromes limfoproliferatives | |
Regulació de l'activitat inflamatòria per IFN-gamma en l'Arteritis de Cèl·lules Gegants (ACG) | |
Response to thalidomide in multiple myeloma: impact of angiogenic factors | |
Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: Relevance for recent optic nerve ischemia | |
SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma. | |
Stimulatory autoantibodies to the PDGF receptor in scleroderma. |